The Scotts Miracle-Gro Company SMG
50.89
(0.24)
(0.47%)
as of 25 Sep
- Market cap
- $3.0B
- P/E
- 40.7×
Follow SMG
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
22.60 | 37.17 | 32.01 | 54.49 |
P/S ratio |
0.96 | 0.99 | 1.02 | 1.14 | |
P/FCF ratio |
11.98 | 9.43 | 9.30 | 15.06 | |
P/Operating CF |
18.84 | (9.12) | 16.06 | 11.47 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.57 | 1.73 | 1.69 | 1.74 | |
EV/EBITDA |
12.35 | 12.90 | 11.60 | 13.38 | |
EV/Operating CF |
14.42 | 13.22 | 12.29 | 16.38 | |
EV/FCF |
19.55 | 16.47 | 15.47 | 22.98 | |
Quick Ratio |
0.26 | 0.22 | 0.61 | 0.67 | |
Current Ratio |
1.27 | 1.35 | 1.27 | 1.21 | |
Net Debt/EBITDA |
(13.95) | (741.24) | 5.60 | 11.19 | |
Debt/Assets |
76.82% | 83.34% | 68.81% | 66.72% | |
Debt/Equity |
(5.89) | (5.05) | (8.19) | (10.13) | |
Asset Turnover |
1.22 | 1.10 | 1.00 | 1.11 | |
Operating CF/Net income |
(1.15) | 2.96 | 0.92 | 3.08 | |
Capex/Depreciation |
(2.32) | (1.09) | (1.16) | (1.47) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
33.63% | 29.91% | 13.65% | 12.42% | |
Intangible Assets out of Total Assets |
0.22 | 0.20 | 0.17 | 0.19 | |
Share Based Compensation of Revenue |
2.69% | 2.09% | 1.29% | 1.02% | |
Graham Net Nets |
(0.66) | (0.67) | (0.59) | (0.51) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
4.42% | 2.69% | 3.12% | 1.84% | |
Free Cash Flow Yield |
8.35% | 10.60% | 10.75% | 6.64% | |
Revenue per Share |
8.64 | 6.12 | 25.12 | 20.14 | |
Operating CF per Share |
3.02 | (6.40) | 3.79 | 5.94 | |
Capex per Share |
(0.74) | (0.35) | (0.32) | (0.42) | |
Free Cash Flow per Share |
2.28 | (6.74) | 3.47 | 5.52 | |
Cash per Share |
0.57 | 0.14 | 0.11 | 0.48 | |
Shareholders Equity per Share |
(6.21) | (8.65) | (4.93) | (3.59) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(6.21) | (8.65) | (4.93) | (3.59) | |
Free Cash Flow |
131.20 | (390.40) | 201.40 | 321.10 | |
Working Capital |
200.60 | 324.80 | 346.30 | 238.30 | |
Capital Expenditures |
(42.90) | (20.00) | (18.60) | (24.50) | |
Net Current Asset Value |
(2,159.20) | (2,277.40) | (2,076.60) | (2,027.00) | |
EV/EBIT |
14.93 | 15.42 | 13.51 | 15.82 | |
Capex to Sales |
0.09 | 0.06 | 0.01 | 0.02 | |
Net Profit Margin |
(30.53%) | (35.27%) | 16.35% | 9.57% | |
Price to Operating Income |
9.15 | 8.83 | 8.13 | 10.36 | |
| Other line items | |||||
Average Receivables |
168.80 | 183.40 | 767.25 | 629.35 | |
Average Payables |
238.05 | 284.15 | 384.20 | 278.30 | |
Average Inventory |
565.10 | 845.80 | 702.80 | 483.40 | |
Average Assets |
2,806.95 | 3,102.10 | 3,474.35 | 3,129.00 | |
Average Common Equity |
(374.05) | (490.05) | (288.30) | (189.80) |
Columns are period end dates